BaseClear offers complete solutions to analyse the interactions between drugs and the microbiota in clinical trials. The microbiota plays an important role in the efficacy, effectiveness and safety of many drugs, probiotics, cosmetics and other biological compounds. The microbiota influences the bioavailability, toxicity and responsiveness of a patient to a given drug. On the other hand, the patient’s microbiota can predict how the patient responds to a drug.
BaseClear can facilitate the entire realm of microbiome-based clinical research, and offers complete solutions to help determine the effect of drugs, probiotics, cosmetics and other biological compounds on the gut and skin microbiota. Our solutions cover the entire process including sampling, storage, logistics, DNA and/or RNA extraction from difficult samples, collection of metadata, downstream bioinformatics, statistical analysis, optional sharing of results with the clinical trial participants and reporting.